The Fallopian Tube: Primary Site of Most Pelvic High-grade Serous Carcinomas

被引:134
|
作者
Salvador, Shannon [1 ]
Gilks, Blake [2 ]
Koebel, Martin [3 ,5 ,6 ]
Huntsman, David [2 ,3 ,5 ]
Rosen, Barry [7 ]
Miller, Dianne [1 ,4 ]
机构
[1] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC V5Z 1M9, Canada
[2] Univ British Columbia, Dept Pathol, Vancouver, BC V5Z 1M9, Canada
[3] Vancouver Coastal Hlth Res Inst, Dept Pathol, Vancouver, BC, Canada
[4] Vancouver Coastal Hlth Author, Dept Gynecol Oncol, Vancouver, BC, Canada
[5] British Columbia Canc Agcy, Dept Pathol, Vancouver, BC V5Z 4E6, Canada
[6] Charita Hosp, Inst Pathol, Berlin, Germany
[7] Princess Margaret Hosp, Dept Gynecol Oncol, Toronto, ON M4X 1K9, Canada
关键词
High-grade serous carcinoma; Fallopian tube carcinoma; Ovarian cancer; Etiology; EPITHELIAL OVARIAN-CANCER; ORAL-CONTRACEPTIVE USE; INFLAMMATORY-DISEASE; PROPHYLACTIC OOPHORECTOMY; NEISSERIA-GONORRHOEAE; PATHOLOGICAL FINDINGS; MUTATION CARRIERS; FERTILITY DRUGS; HEALTH-BENEFITS; ORGAN-CULTURE;
D O I
10.1111/IGC.0b013e318199009c
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epithelial ovarian cancer is the most common cause of mortality from gynecologic malignancy, and most of epithelial cancers are of serous type. The site of origin of pelvic high-grade serous carcinoma has been the subject of debate for 60 years. This paper reviews the evidence that pelvic serous carcinoma originates from the fallopian tube mucosa and puts forward a theory that inflammation in the tube, caused by menstrual cytokines or infection, is critical to the genesis of these tumors. Other risk factors for pelvic serous carcinoma will be reviewed, including oral contraceptive use, parity, infertility, and tubal ligation. Studies were identified for this review by searching the English language literature in the MEDLINE database between the years 1995 and 2007 using the following keywords: fallopian tube neoplasia, ovarian serous adenocarcinoma, pregnancy, oral contraceptive, infertility, pelvic inflammatory disease, cytokines, menstruation, and tubal ligation, followed by an extensive review of bibliographies from articles found through the search. The clinical implications of this theory are discussed, and a change in surgical practice is recommended, with salpingectomy at the time of simple hysterectomy. This theory also has implications for the development of new methods of screening for pelvic serous carcinomas, as there are no screening methods that arc currently available to find this form of cancer in an early stage. Inflammatory markers could be detected in the vagina from the fallopian tube indicating possible chronic inflammation and a risk factor for mutagenesis leading to serous carcinoma.
引用
收藏
页码:58 / 64
页数:7
相关论文
共 50 条
  • [31] Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneum
    Ohsuga, Takuma
    Yamaguchi, Ken
    Kido, Aki
    Murakami, Ryusuke
    Abiko, Kaoru
    Hamanishi, Junzo
    Kondoh, Eiji
    Baba, Tsukasa
    Konishi, Ikuo
    Matsumura, Noriomi
    BMC CANCER, 2017, 17
  • [32] The Fallopian Tube as the Origin of High Grade Serous Ovarian Cancer: Review of a Paradigm Shift
    Reade, Clare J.
    Mcvey, Ruaidhri M.
    Tone, Alicia A.
    Finlayson, Sarah J.
    McAlpine, Jessica N.
    Fung-Kee-Fung, Michael
    Ferguson, Sarah E.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2014, 36 (02) : 133 - 140
  • [33] An orthotopic model of platinum-sensitive high grade serous fallopian tube carcinoma
    Khabele, Dineo
    Fadare, Oluwole
    Liu, Annie Y.
    Wilson, Andrew J.
    Wass, Erika
    Osteen, Kevin
    Crispens, Marta A.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2012, 5 (01): : 37 - 45
  • [34] High-grade serous cancer of left fallopian tube with right inguinal lymph node enlargement: a case report
    Zhou, Aizhi
    Gu, Weiyong
    Yang, Yumei
    Chen, Xin
    Ye, Wenfeng
    Wang, Mei
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [35] Evolutionary mode and timing of dissemination of high-grade serous carcinomas
    Sveen, Anita
    Johannessen, Bjarne
    Klokkerud, Solveig M. K.
    Kraggerud, Sigrid M.
    Meza-Zepeda, Leonardo A.
    Bjornslett, Merete
    Bischof, Katharina
    Myklebost, Ola
    Tasken, Kjetil
    Skotheim, Rolf I.
    Dorum, Anne
    Davidson, Ben
    Lothe, Ragnhild A.
    JCI INSIGHT, 2024, 9 (03)
  • [36] High-Grade Serous Tumor Arising from Fallopian Tube in a BRCA Mutation Carrier after Prophylactic Oophorectomy
    Lorusso, Domenica
    Di Rocco, Roberta
    Mancini, Maria
    Raspagliesi, Francesco
    CASE REPORTS IN ONCOLOGY, 2013, 6 (01): : 21 - 24
  • [37] Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma
    Zhang, Shuang
    Dolgalev, Igor
    Zhang, Tao
    Ran, Hao
    Levine, Douglas A.
    Neel, Benjamin G.
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [38] Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomas
    Kosuke Hiramatsu
    Kiyoshi Yoshino
    Satoshi Serada
    Kosuke Yoshihara
    Yumiko Hori
    Minoru Fujimoto
    Shinya Matsuzaki
    Tomomi Egawa-Takata
    Eiji Kobayashi
    Yutaka Ueda
    Eiichi Morii
    Takayuki Enomoto
    Tetsuji Naka
    Tadashi Kimura
    British Journal of Cancer, 2016, 114 : 554 - 561
  • [39] Similar protein expression profiles of ovarian and endometrial high-grade serous carcinomas
    Hiramatsu, Kosuke
    Yoshino, Kiyoshi
    Serada, Satoshi
    Yoshihara, Kosuke
    Hori, Yumiko
    Fujimoto, Minoru
    Matsuzaki, Shinya
    Egawa-Takata, Tomomi
    Kobayashi, Eiji
    Ueda, Yutaka
    Morii, Eiichi
    Enomoto, Takayuki
    Naka, Tetsuji
    Kimura, Tadashi
    BRITISH JOURNAL OF CANCER, 2016, 114 (05) : 554 - 561
  • [40] Architectural Patterns of Ovarian/Pelvic High-grade Serous Carcinoma
    Bromley, Amy B.
    Altman, Alon D.
    Chu, Pamela
    Nation, Jill G.
    Nelson, Gregg S.
    Ghatage, Praful
    Kalloger, Steve E.
    Han, Guangming
    Koebel, Martin
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2012, 31 (05) : 397 - 404